Cell Signaling Technology

OCRL1 Antibody

#8797 · $317

100
Citing papers
5k
Combined citations
Supplier page Find this product

Research areas

Parkinson's Disease Mechanisms and Treatments12Ubiquitin and proteasome pathways7Cell death mechanisms and regulation6Cancer-related Molecular Pathways6Nerve injury and regeneration5Immune Cell Function and Interaction5Muscle metabolism and nutrition5interferon and immune responses4

Papers citing this product

1
Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity
Human Molecular Genetics·2005·360 cit.·DOI
2
TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation
Cell Death and Differentiation·2012·354 cit.·DOI
3
S100B Protein Stimulates Microglia Migration via RAGE-dependent Up-regulation of Chemokine Expression and Release
Journal of Biological Chemistry·2011·238 cit.·DOI
4
Hyperglycaemia-induced pro-inflammatory responses by retinal Müller glia are regulated by the receptor for advanced glycation end-products (RAGE)
Diabetologia·2010·199 cit.·DOI
5
Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer
Nature Genetics·2018·195 cit.·DOI
6
Urolithin A suppresses high glucose-induced neuronal amyloidogenesis by modulating TGM2-dependent ER-mitochondria contacts and calcium homeostasis
Cell Death and Differentiation·2020·178 cit.·DOI
7
Tuning sensitivity to IL-4 and IL-13: differential expression of IL-4Rα, IL-13Rα1, and γc regulates relative cytokine sensitivity
The Journal of Experimental Medicine·2008·151 cit.·DOI
8
Mutant LRRK2 Toxicity in Neurons Depends on LRRK2 Levels and Synuclein But Not Kinase Activity or Inclusion Bodies
Journal of Neuroscience·2014·140 cit.·DOI
9
Tau Enhances α-Synuclein Aggregation and Toxicity in Cellular Models of Synucleinopathy
PLoS ONE·2011·139 cit.·DOI
10
α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson’s disease
JCI Insight·2021·136 cit.·DOI